Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    One-Year Vision Outcomes of Age-Related Macular Degeneration in Mongolians
    (Mongolian National University of Medical Sciences, 2024-03-06) ; ; ;
    Objectives: To assess the post-treatment vision outcomes in Mongolian patients with age-related macular degeneration. Methods: Surveys assessed subjects' antioxidant intake, age, gender, race, body mass index, hypertension, smoking habits, and sunlight exposure. Results: There were 136 cases and 100 controls, of whom 130 (55.1%) were female. Of the cases, 100 individuals had the dry type of AMD, while 36 participants had the wet type of AMD. The mean ages of the dry and wet AMD groups and controls were 75.33 ± 6.98 years, 76.0 ± 5.57 years, and 67.03 ± 7.14 years, respectively-the change of central retinal thickness and intraocular pressure by month. Our current study found that the central retinal thickness of the dry AMD group did not decrease compared to the baseline. However, the value decreased from 269.9 ± 89.17 (baseline) to 218.33 ± 41.35 at the 3-month follow-up. Concerning the intraocular pressure of all subjects, the baseline pressure of the dry AMD group was 13.88 ± 3.02, and the value was increased to 14.28 ± 2.27 after one year of treatment. In the wet AMD group, the baseline value was 14.06 ± 3.58, rising to 14.42 ± 3.51 at one-year follow-up. Conclusion: A larger sample may produce different and better results.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Identifying Risk Factors for Impaired Pulmonary Function in COVID-19 Patients: Cross-Sectional Study
    (Mongolian National University of Medical Sciences, 2025-03-31)
    Bayaraa, Odonchimeg
    ;
    ; ; ;
    Objective: COVID-19 has an impact on various organs, including heart, kidney, lung, and liver. However, respiratory system has been the primary organ mostly affected, ranging from asymp tomatic to critical stages of the disease. The risk of developing impaired pulmonary function depends on multiple factors, including demographic and clinical manifestations such as severi ty of the disease, comorbidities, and treatment options. As the number of new COVID-19 cases declines, public health experts and medical doctors are increasingly interested in conditions after COVID-19 and are working to improve the quality of life for affected patients. Our study aim was to investigate risk factors associated with impaired pulmonary function in individuals recovered from severe COVID-19. Method: The study was conducted using a hospital-based, cross-sectional study design. A total of 268 participants who visited the Pulmonology and Allergology Center of The First Central Hospital of Mongolia for a follow-up examination one year after contracting COVID-19 between 2022 and 2023. Demographic data, comorbidities, severity of initial infection, hospitalization history, and spirometry were analyzed to determine their association with post-COVID-19 impairment of pulmonary function. Results: This study identified the risk factors significantly associated with altered pulmonary function in post COVID-19. 50.4% of individuals with initial severe infection had altered pulmonary function. Severe group had higher odds of decreasing FVC (predicted %) compared to the asymptomatic group (OR=3.69; 95% CI; P =0.003). For comorbidities, patients with cardiovascular disease were significantly more likely to decrease FVC (predicted %) compared to participants who had no comorbidities (OR=4.22; 95% CI; P =0.040). Moreover, patients with chronic lung diseases had a significantly high of impaired FVC (%), with an adjusted odds ratio of 2.46 (95% CI, P =0.005) Conclusion: Patients with pre-existing cardiovascular and chronic lung diseases, and severe initial infection have a significantly higher likelihood of impaired pulmonary function compared to those with other comorbidities, and non-severe COVID-19.